Novo Nordisk A/S Common Stock (NVO)
Total Costs & Expenses
kr 51.43B
Quarterly · Period ending: · DKK
NVO Total Costs & Expenses
Latest reportedkr 51.43B DKKperiod ending
Latest reportedkr 51.43B DKKperiod ending
NVO Quarterly Total Costs & Expenses · DKK (kr 985.86M → kr 51.43B)
Quarterly Total Costs & Expenses
High-resolution chart · PNG
NVO total costs & expenses history
Quarterly · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Costs & Expenses (DKK) |
|---|---|
| 5,745,676,000 | |
| 5,346,381,000 | |
| 2,165,941,000 | |
| 15,344,603,000 | |
| 6,484,813,000 | |
| 5,562,917,000 | |
| 5,562,567,000 | |
| 5,823,171,000 | |
| 5,022,575,000 | |
| 4,631,290,000 | |
| 4,875,167,000 | |
| 5,034,765,000 | |
| 4,568,091,000 | |
| 4,192,679,000 | |
| 4,687,576,000 | |
| 4,315,842,000 | |
| 4,124,682,000 | |
| 3,627,146,000 | |
| 4,201,368,000 | |
| 3,669,035,000 | |
| 3,507,569,000 | |
| 3,434,748,000 | |
| 3,410,901,000 | |
| 3,217,961,000 | |
| 3,573,302,000 | |
| 3,370,631,000 | |
| 3,557,163,000 | |
| 3,374,955,000 | |
| 3,423,015,000 | |
| 3,111,335,000 | |
| 4,241,370,000 | |
| 3,131,168,000 | |
| 3,003,501,000 | |
| 2,626,239,000 | |
| 2,714,161,000 | |
| 2,565,661,000 | |
| 2,809,229,000 | |
| 2,661,793,000 | |
| 2,944,439,000 | |
| 2,392,853,000 | |
| 2,248,956,000 | |
| 2,276,339,000 | |
| 2,325,934,000 | |
| 2,029,456,000 | |
| 2,031,635,000 | |
| 1,940,479,000 | |
| 2,144,853,000 | |
| 1,747,800,000 | |
| 1,757,120,000 | |
| 1,975,761,000 | |
| 1,635,862,000 | |
| 1,320,283,000 | |
| 1,387,078,000 | |
| 1,187,376,000 | |
| 1,383,534,000 | |
| 1,271,250,000 | |
| 1,167,516,000 | |
| 1,227,832,000 | |
| 1,044,332,000 | |
| 1,014,592,000 | |
| 1,109,964,000 | |
| 1,025,543,000 | |
| 1,041,366,000 | |
| 985,861,500 |